AstraZeneca has seen major momentum in oncology in recent years. It got a big showcase at Europe's top cancer conference.
After 100 years, there's finally an effective cancer vaccine. Now comes the push to get them to work in more tumor types.
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Get notified when the next part drops Sign up for Health Care Inc., STAT’s free weekly newsletter about the business of health care, to find out when each story is published. You’ll also get sharp ...
I felt Christina Applegate’s disappointment as if it were my own — because not long ago, it was,” writes Lindsay Karp.
Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes ...
A multiple sclerosis treatment from Novartis cut by a third the rates of relapses that people with the condition have ...
A new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.
Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early ...
Five years after being diagnosed with multiple sclerosis, actor Christina Applegate revealed this week that she had been ...
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality ...
What state officials scrambling to implement Medicaid work requirements shared behind closed doors at the National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results